XBIOTECH INC. Interest Receivable, Current
XBIOTECH INC. (XBIT) had Interest Receivable, Current of $277.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Nontrade Receivables, Current
us-gaap:InterestReceivableCurrent · last filed 2026-08-13
- 2026-06-30: Interest Receivable, Current $277.00K.
- 2026-03-31: Interest Receivable, Current $302.00K.
- 2025-12-31: Interest Receivable, Current $360.00K.
- 2024-12-31: Interest Receivable, Current $700.00K.
| Period end | Interest Receivable, Current |
|---|---|
| 2026-06-30 | $277.00K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $302.00K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $360.00K 10-Q · filed 2026-08-13 |
| 2024-12-31 | $700.00K 10-K · filed 2026-03-13 |
| 2023-12-31 | $860.00K 10-K · filed 2025-03-18 |
| 2023-06-30 | $3.22M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $2.37M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $1.22M 10-K · filed 2024-03-15 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |